Welcome to LookChem.com Sign In|Join Free

CAS

  • or

145090-28-4

Post Buying Request

145090-28-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

145090-28-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 145090-28-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,5,0,9 and 0 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 145090-28:
(8*1)+(7*4)+(6*5)+(5*0)+(4*9)+(3*0)+(2*2)+(1*8)=114
114 % 10 = 4
So 145090-28-4 is a valid CAS Registry Number.
InChI:InChI=1/C12H15N3/c13-9-12(14)6-7-15(10-12)8-11-4-2-1-3-5-11/h1-5H,6-8,10,14H2

145090-28-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-amino-1-benzylpyrrolidine-3-carbonitrile

1.2 Other means of identification

Product number -
Other names 3-Amino-1-benzyl-3-cyanopyrrolidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:145090-28-4 SDS

145090-28-4Relevant articles and documents

G protein coupled receptor agonist and application thereof in treatment of diabetes

-

Paragraph 0016, (2018/06/16)

The invention discloses a structure of a compound. The structural formula of the compound is shown in the description. Found by activity determination, the structure has the effect of a G protein coupled receptor 119 agonist; the G protein coupled receptor 119 agonist has the functions of not causing hypoglycemia of patients and promoting GLP-1 secretion. The compound disclosed by the invention can be further researched and developed as a diabetes-resisting drug. Besides, the invention further discloses a synthesis route and a synthesis method for the compound.

A reversible cysteines protease aminonitrile effective as a new

-

Page/Page column 91-92, (2008/06/13)

Disclosed are novel nitrile compounds of formula (I) further defined herein, which compounds are useful as reversible inhibitors of cysteine proteases such as cathepsin K, S, F, L and B. These compounds are useful for treating diseases and pathological co

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 145090-28-4